@article{ali:hal-03548805, TITLE = {{BP180-specific IgG is associated with skin adverse events, therapy response, and overall survival in non-small cell lung cancer patients treated with checkpoint inhibitors}}, AUTHOR = {Ali, Omar Hasan and Bomze, David and Ring, Sandra S. and Berner, Fiamma and Fassler, Mirjam and Diem, Stefan and Abdou, Marie-Therese and Hammers, Christoph and Emtenani, Shirin and Braun, Anne and Cozzio, Antonio and Mani, Bernhard and Jochum, Wolfram and Schmidt, Enno and Zillikens, Detlef and Sadik, Christian D. and Flatz, Lukas}, URL = {https://u-picardie.hal.science/hal-03548805}, JOURNAL = {{Journal of The American Academy of Dermatology}}, PUBLISHER = {{Elsevier}}, VOLUME = {82}, NUMBER = {4}, PAGES = {854-861}, YEAR = {2020}, DOI = {10.1016/j.jaad.2019.08.045}, KEYWORDS = {anti-PD1 ; autoantibodies ; immune checkpoint inhibitors ; immune-related adverse events ; non-small cell lung cancer ; skin rash}, HAL_ID = {hal-03548805}, HAL_VERSION = {v1}, }